Yingjun Zhao

Viva Biotech (China) — China

Biochemistry, Genetics and Molecular Biology · Life Sciences

37h-index5.7kcitations57works0.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

RNA modifications and cancer(23), MicroRNA in disease regulation(22), Cancer-related molecular mechanisms research(21), RNA Research and Splicing(11), Cancer, Hypoxia, and Metabolism(8)

Publications57 total

Abstract 5444: ImmuMab® mice enable efficient development of antibody therapeutics by unparalleled diversity across multiple formats
Cancer Research·2025
Erratum: Mitogen-activated protein kinase kinase kinase 4 deficiency in intrahepatic cholangiocarcinoma leads to invasive growth and epithelial-mesenchymal transition
Hepatology·2025
Erratum: MiR-199a-5p is negatively associated with malignancies and regulates glycolysis and lactate production by targeting hexokinase 2 in liver cancer
Hepatology·2025
Erratum: Protein tyrosine phosphatase receptor S acts as a metastatic suppressor in hepatocellular carcinoma by control of epithermal growth factor receptor–induced epithelial-mesenchymal transition
Hepatology·2025
MicroRNA-148a-3p suppresses the glycolysis and Cell proliferation by targeting transmembrane protein 54 in liver cancer
Biochemical and Biophysical Research Communications·2023· 6 citedOpen Access
Functional significance of cholesterol metabolism in cancer: from threat to treatment
Experimental & Molecular Medicine·2023· 178 citedOpen Access
Supplementary Tables from MetaLnc9 Facilitates Lung Cancer Metastasis via a PGK1-Activated AKT/mTOR Pathway
2023Open Access
Data from MetaLnc9 Facilitates Lung Cancer Metastasis via a PGK1-Activated AKT/mTOR Pathway
2023Open Access
Supplementary Tables from MetaLnc9 Facilitates Lung Cancer Metastasis via a PGK1-Activated AKT/mTOR Pathway
2023Open Access
Data from MetaLnc9 Facilitates Lung Cancer Metastasis via a PGK1-Activated AKT/mTOR Pathway
2023Open Access
Hypoxia-induced downregulation of microRNA-186-5p in endothelial cells promotes non-small cell lung cancer angiogenesis by upregulating protein kinase C alpha
Molecular Therapy — Nucleic Acids·2023· 19 citedOpen Access
Signaling pathways in cancer‐associated fibroblasts: recent advances and future perspectives
Cancer Communications·2022· 232 citedOpen Access
Liquid–liquid phase separation in tumor biology
Signal Transduction and Targeted Therapy·2022· 235 citedOpen Access
RNA binding protein RALY activates the cholesterol synthesis pathway through an MTA1 splicing switch in hepatocellular carcinoma
Cancer Letters·2022· 30 cited
Suppression of endothelial miR-22 mediates non-small cell lung cancer cell-induced angiogenesis
Molecular Therapy — Nucleic Acids·2021· 18 citedOpen Access
Suppression of endothelial miR-22-3p mediates non-small cell lung cancer cell-induced angiogenesis
2021· 1 citedOpen Access
Gain of LINC00624 Enhances Liver Cancer Progression by Disrupting the Histone Deacetylase 6/Tripartite Motif Containing 28/Zinc Finger Protein 354C Corepressor Complex
Hepatology·2020· 90 cited
Inflammation‐Induced Long Intergenic Noncoding RNA (LINC00665) Increases Malignancy Through Activating the Double‐Stranded RNA–Activated Protein Kinase/Nuclear Factor Kappa B Pathway in Hepatocellular Carcinoma
Hepatology·2020· 78 cited
Splicing Regulator p54nrb/Non–POU Domain–Containing Octamer‐Binding Protein Enhances Carcinogenesis Through Oncogenic Isoform Switch of MYC Box–Dependent Interacting Protein 1 in Hepatocellular Carcinoma
Hepatology·2019· 65 cited
Tumor‐Specific Transcripts Are Frequently Expressed in Hepatocellular Carcinoma With Clinical Implication and Potential Function
Hepatology·2019· 31 citedOpen Access
page 1 of 3Next →

Frequent Co-authors

Xianghuo He(33), Shenglin Huang(17), Jie Ding(14), Ming Yao(12), Jinjun Li(12), Zhiao Chen(11), Weijie Guo(10), Linhui Liang(9), Taoyang Chen(9), Shengli Li(9), Qiang Gao(9), Jianren Gu(8), Zhe Li(8), Jia Fan(8), Zhixiang Hu(7), Ruopeng Zha(7), Jiwei Zhang(6), Zhen‐Bin Ding(6), Jian Zhou(6), Mingxia Yan(5)